Technical Analysis for CTLT - Catalent, Inc.

Grade Last Price % Change Price Change
grade B 53.15 -3.78% -2.09
CTLT closed down 3.78 percent on Friday, August 23, 2019, on 1.33 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Earnings due: Aug 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical CTLT trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
20 DMA Resistance Bearish -3.78%
Down 3 Days in a Row Weakness -3.78%
20 DMA Resistance Bearish -4.58%
Fell Below 20 DMA Bearish -4.70%

Older signals for CTLT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segment's oral dose forms include softgel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scientific services, stability testing, respiratory products formulation and manufacturing, regulatory consulting, and bioanalytical testing for biologic products. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.
Biotechnology Biopharmaceutical Manufacturing Life Sciences Pharmaceutical Industry Pharmacy Pharmacology Dosage Forms Biologic Products Specialty Drugs In The United States Consumer Health Products Inventory Management Services
Is CTLT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 58.38
52 Week Low 29.23
Average Volume 676,407
200-Day Moving Average 43.8227
50-Day Moving Average 54.5982
20-Day Moving Average 55.8065
10-Day Moving Average 55.437
Average True Range 1.4414
ADX 20.78
+DI 17.4999
-DI 25.3537
Chandelier Exit (Long, 3 ATRs ) 54.0558
Chandelier Exit (Short, 3 ATRs ) 57.2942
Upper Bollinger Band 58.1041
Lower Bollinger Band 53.5089
Percent B (%b) -0.08
BandWidth 8.234166
MACD Line 0.13
MACD Signal Line 0.4929
MACD Histogram -0.3629
Fundamentals Value
Market Cap 6.66 Billion
Num Shares 125 Million
EPS 0.87
Price-to-Earnings (P/E) Ratio 61.09
Price-to-Sales 2.57
Price-to-Book 7.36
PEG Ratio 3.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 57.04
Resistance 3 (R3) 57.41 56.48 56.39
Resistance 2 (R2) 56.48 55.49 56.30 56.17
Resistance 1 (R1) 54.82 54.88 54.36 54.45 55.96
Pivot Point 53.89 53.89 53.66 53.71 53.89
Support 1 (S1) 52.23 52.90 51.77 51.86 50.34
Support 2 (S2) 51.30 52.29 51.12 50.13
Support 3 (S3) 49.64 51.30 49.91
Support 4 (S4) 49.27